Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sunil J Advani

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genesSunil J Advani, Ralph R Weichselbaum, Bernard Roizman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Enhancing radiotherapy with genetically engineered virusesSunil J Advani, Ralph R Weichselbaum, Steven J Chmura
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
ReVOLT: radiation-enhanced viral oncolytic therapySunil J Advani, James J Mezhir, Bernard Roizman, et al.
Journal of Virology|October 29, 2003
Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1Sunil J Advani, Lizette O Durand, Ralph R Weichselbaum, et al.
Journal of Virology|May 14, 2005
The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1Lizette O Durand, Sunil J Advani, Alice P W Poon, et al.
Frontiers in Oncology|July 6, 2026
Past present and future of radiosensitization in cervical cancerOlivia N Julian, Isabella Velarde, Sunil J Advani, et al.
NPJ Precision Oncology|April 3, 2025
Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapiesMahsa Mortaja, Stephen R Adams, Rana R McKay, et al.
Pharmaceutics|April 3, 2021
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory DrugsDina V Hingorani, Maria F Camargo, Maryam A Quraishi, et al.
Future Oncology (London, England)|November 3, 2011
DNA damage response and repair: insights into strategies for radiation sensitization of gliomasSantosh Kesari, Sunil J Advani, Joshua D Lawson, et al.
Nature Communications|September 4, 2015
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2Sunil J Advani, Maria Fernanda Camargo, Laetitia Seguin, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|April 1, 2003
Herpes simplex virus 1 activates cdc2 to recruit topoisomerase II alpha for post-DNA synthesis expression of late genesSunil J Advani, Ralph R Weichselbaum, Bernard Roizman
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2007
Enhancing radiotherapy with genetically engineered virusesSunil J Advani, Ralph R Weichselbaum, Steven J Chmura
International Journal of Radiation Oncology, Biology, Physics|October 3, 2006
ReVOLT: radiation-enhanced viral oncolytic therapySunil J Advani, James J Mezhir, Bernard Roizman, et al.
Journal of Virology|October 29, 2003
Oct-1 is posttranslationally modified and exhibits reduced capacity to bind cognate sites at late times after infection with herpes simplex virus 1Sunil J Advani, Lizette O Durand, Ralph R Weichselbaum, et al.
Journal of Virology|May 14, 2005
The carboxyl-terminal domain of RNA polymerase II is phosphorylated by a complex containing cdk9 and infected-cell protein 22 of herpes simplex virus 1Lizette O Durand, Sunil J Advani, Alice P W Poon, et al.
Frontiers in Oncology|July 6, 2026
Past present and future of radiosensitization in cervical cancerOlivia N Julian, Isabella Velarde, Sunil J Advani, et al.
NPJ Precision Oncology|April 3, 2025
Spatially precise chemo-radio-immunotherapy by antibody drug conjugate directed tumor radiosensitization to potentiate immunotherapiesMahsa Mortaja, Stephen R Adams, Rana R McKay, et al.
Pharmaceutics|April 3, 2021
Tumor Activated Cell Penetrating Peptides to Selectively Deliver Immune Modulatory DrugsDina V Hingorani, Maria F Camargo, Maryam A Quraishi, et al.
Future Oncology (London, England)|November 3, 2011
DNA damage response and repair: insights into strategies for radiation sensitization of gliomasSantosh Kesari, Sunil J Advani, Joshua D Lawson, et al.
Nature Communications|September 4, 2015
Kinase-independent role for CRAF-driving tumour radioresistance via CHK2Sunil J Advani, Maria Fernanda Camargo, Laetitia Seguin, et al.
Pageof 4